{"id":155516,"date":"2021-05-26T01:51:16","date_gmt":"2021-05-26T05:51:16","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/ose-immunotherapeutics-announces-dosing-of-the-first-healthy-volunteer-in-phase-1-clinical-trial-of-its-multi-variant-second-generation-covid-19\/"},"modified":"2024-08-18T11:42:48","modified_gmt":"2024-08-18T15:42:48","slug":"ose-immunotherapeutics-announces-dosing-of-the-first-healthy-volunteer-in-phase-1-clinical-trial-of-its-multi-variant-second-generation-covid-19","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/ose-immunotherapeutics-announces-dosing-of-the-first-healthy-volunteer-in-phase-1-clinical-trial-of-its-multi-variant-second-generation-covid-19.php","title":{"rendered":"OSE Immunotherapeutics Announces Dosing of the First Healthy Volunteer in  Phase 1 Clinical Trial of its Multi-Variant Second-Generation COVID-19&#8230;"},"content":{"rendered":"<p><![CDATA[NANTES, France, May  26, 2021  (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) today announced that the first healthy volunteer has been enrolled and dosed in the Phase 1 clinical trial evaluating its COVID-19 vaccine, named CoVepiT.]]><\/p>\n<p>Read more from the original source:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"https:\/\/www.globenewswire.com\/news-release\/2021\/05\/26\/2236023\/0\/en\/OSE-Immunotherapeutics-Announces-Dosing-of-the-First-Healthy-Volunteer-in-Phase-1-Clinical-Trial-of-its-Multi-Variant-Second-Generation-COVID-19-Vaccine.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"OSE Immunotherapeutics Announces Dosing of the First Healthy Volunteer in  Phase 1 Clinical Trial of its Multi-Variant Second-Generation COVID-19...\">OSE Immunotherapeutics Announces Dosing of the First Healthy Volunteer in  Phase 1 Clinical Trial of its Multi-Variant Second-Generation COVID-19...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read more from the original source: OSE Immunotherapeutics Announces Dosing of the First Healthy Volunteer in Phase 1 Clinical Trial of its Multi-Variant Second-Generation COVID-19... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/ose-immunotherapeutics-announces-dosing-of-the-first-healthy-volunteer-in-phase-1-clinical-trial-of-its-multi-variant-second-generation-covid-19.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-155516","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/155516"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=155516"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/155516\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=155516"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=155516"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=155516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}